When was Seegene Technologies founded?

Seegene Technologies was founded in 2000 and raised its 1st funding round 19 years after it was founded.

Where is Seegene Technologies located?

Seegene Technologies is headquartered in Seoul, South Korea.

Who is the current CEO of Seegene Technologies?

Jong Yoon Chun of Seegene Technologies.

How many employees does Seegene Technologies have?

As of Aug 31, 2026, the latest employee count at Seegene Technologies is 508.

Is Seegene Technologies a funded company?

Seegene Technologies is a funded company, having raised a total of $***** in its 1st and only funding round, a Grant (prize money) round on Dec 01, 2019.

When was the latest funding round of Seegene Technologies?

Seegene Technologies' latest funding was a $***** Grant (prize money) round on Dec 01, 2019, with participation from 1 investor.

What is the annual revenue of Seegene Technologies?

Annual revenue of Seegene Technologies is between $100M and $500M as on Dec 31, 2023

Where does Seegene Technologies rank among its competitors?

Seegene Technologies ranks 46th amongst 2374 active competitors, of which 546 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Antheia, which secured $24M in Jan, 2026.

Who are the top competitors of Seegene Technologies?

Seegene Technologies' top competitors include Adaptive Biotechnologies, MeMed and HaystackAnalytics. Among them, Antheia secured the most recent funding round in January, 2026.

Seegene Technologies - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Provider of advanced molecular diagnostics solutions. It is focused on improving global healthcare outcomes through innovative assay design, automated laboratory systems, and real-time data platforms. Offers high-multiplex syndromic panel assays covering respiratory, gastrointestinal, reproductive, and other infections, alongside unattended PCR automation and integrated data analytics for population-level and clinical insights. It enable rapid, accurate, and scalable detection of infectious diseases, antimicrobial resistance, and genetic markers, helping drive timely clinical decisions, infection prevention, and public health responses.

Website: www.seegene.com/
Social

Key Metrics

Founded Year

2000

Location

Seoul, South Korea

Stage

Public

Latest Funding Round

Grant (prize money), Dec 01, 2019, $*****

Investors

Songhyun Investment & 4 more

Ranked

46^th among 2374 active competitors

Annual Revenue

$100M - $500M as on Dec 31, 2023

Employee Count

508 as on Aug 31, 2026

Investment & Acquisitions

BREX & 1 more

Similar Companies

Adaptive Biotechnologies & 3161 more

Exit Details

Public

View Seegene Technologies' full profile

Seegene Technologies is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Seegene Co., Ltd CIN: 110-81-47859 , South Korea, Active	Sep 18, 2000	$100M - $500M (As on Dec 31, 2023)	-	-

Seegene Technologies got listed on Sep 10, 2010.

Click here to take a look at Seegene Technologies's IPO in detail

Seegene Technologies has raised funding over 1 round. Its latest funding round was a Grant (prize money) round on Dec 01, 2019 for $*****. 1 investor participated in its latest round. Seegene Technologies has 5 institutional investors.

Here is the list of recent funding rounds of Seegene Technologies:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 01, 2019	2579620	Grant (prize money)	2843286	9835167	4937961	9154951

Access funding benchmarks and valuations. Sign up today!

View details of Seegene Technologies's funding rounds and investors

Seegene Technologies' employee count trend

Seegene Technologies has 508 employees as of Aug 26. Here is Seegene Technologies's employee count trend over the years:

Employee count trend for Seegene Technologies

Uncover Seegene Technologies' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Seegene Technologies include Adaptive Biotechnologies, MeMed and HaystackAnalytics. Here is the list of Top 10 competitors of Seegene Technologies, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Adaptive Biotechnologies 2009, Seattle (United States), Public	Provider of clinical diagnostics, and drug discovery for immune diseases	$419M	Viking Global Investors, Matrix & 21 others	72/100
2nd	MeMed 2009, Tirat Carmel (Israel), Series D	Provider of machine learning based diagnostic solutions for infectious diseases	$163M	La Maison Partners, Ping An & 23 others	69/100
3rd	HaystackAnalytics 2018, Mumbai (India), Seed	Provider of genomics technology for personalized clinical decisions	$17.3M	STRIVE, Sun Pharma & 33 others	67/100
4th	OpGen 2002, Rockville (United States), Public	Developer of diagnostics and bioinformatics platforms for providers	$77.5M	Cross Creek, 180 Degree Capital & 12 others	67/100
5th	Antheia 2013, Palo Alto (United States), Series C	Genetically engineered yeast cells to produce medicinal products	$176M	Viking Global Investors, ATHOS KG & 15 others	67/100
6th	Transcenta 2019, Suzhou (China), Public	Developer of antibody-based therapeutics	$205M	Lilly Asia Ventures, Temasek & 11 others	66/100
7th	Akeso 2012, Zhongshan (China), Public	Developer of antibody drug conjugates for the treatment of broad spectrum diseases	$195M	Loayal Valley Capital, Sino Biopharmaceutical ... & 18 others	65/100
8th	Korro Bio 2018, Cambridge (United States), Public	Provider of RNA editing technologies to develop genetic medicines for rare and prevalent diseases	$4M	Cormorant Asset Management, Atlas Venture ... & 14 others	64/100
9th	Fermentalg 2005, Libourne (France), Public	Innovating with algae for sustainable solutions in nutrition and environmental impact	$30.3M	Demeter, Smalt Capital & 14 others	63/100
10th	Microban 1994, Huntersville (United States), Acquired	Antimicrobial and odor control technologies for durable product protection and freshness	$64.6M	TA Associates, UBS & 1 others	63/100
46th	Seegene Technologies 2000, Seoul (South Korea), Public	Provider of advanced molecular diagnostics solutions	-	Songhyun Investment, KIC Europe & 3 others	56/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Seegene Technologies's competitors? Click here to see the top ones

Seegene Technologies has made 1 investment in Rebus Biosystems and acquired BREX.

Here is the latest report on Seegene Technologies's sector:

Free

Infectious Diseases - Sector Report

Edition: August, 2026 (69 Pages)

View all reports related to Seegene Technologies

Media has covered Seegene Technologies for a total of 12 events in the last 1 year, 11 of them have been about company updates and 1 about partnerships.